TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Predictive accuracy of MM-SES-CD total score for clinical remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐24 in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐24 in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of saliva AUC0‐24 cut-off
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child high liking for restricted foods and drinks at 5 years old
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal television viewing knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children's television viewing time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: proportion of missed STEMI diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of primary reperfusion therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HAMA score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: less bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maxillary first molar distalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maxillary incisor extrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Local Recurrence (LR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Perceived importance of SPHC support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SF-12 general health score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RMDQ score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving LDL-C <1.4 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Achieving LDL-C <1.0 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of nonadherence to dietary counselling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of IV administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement of PGD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in common grief reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Success rate of ventilation mode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experiences of leadership emergence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean number of casts required for full correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for application and removal of splints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mindful connection to the body
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Session satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Barriers to weight loss
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Reduction in frequency of psychological abuse and neglect
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in Reactive Attachment Disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject Global Aesthetic Improvement Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of 15:0 in plasma cholesteryl esters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of 14:0 in plasma cholesteryl esters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum prealbumin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient‐Generated Subjective Global Assessment (PG‐SGA) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in radiographic bone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in distal tibia vBMDTOT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean change in distal tibia BSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean change in mid-tibia SSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of adverse events (ADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Protective antibody titers of ≥ 0.5 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intentions to resist condom use through noncoercive tactics
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Time to complete second-source verification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of adaptive stratified medicine platform studies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to development of new brain metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Driving pressure at PSV50
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: bladder detrusor pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain VAS scores at flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAP score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment attendance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: homework completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Nasal angle opening distance at 500 µm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trabecular iris surface area at 500 µm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trabecular iris angle at 500 µm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with nursing intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Compliance with healthy lifestyle
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completion times of TUG tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interpretation of medical results by healthcare professionals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of symptomatic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Bayley-III cognitive score <85 at 18-22 months corrected age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: operation rate at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: preoperative waiting time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Vigorous physical activity behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total metabolic equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concordance of dual stain interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric average hazard ratio
Endpoint domain: Mortality/survival
Primary endpoint: Intention to get COVID-19 vaccines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Drooling severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic effect after interventional treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total UPRE (Urinary Pesticide Residue Excretion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in UPDRS motor examination score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stage 2 sleep time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPI Interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDQ
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sustained remission at week 26
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of dental fear in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Empathy scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of current pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markers of insulin sensitivity (adiponectin, IGFBP‐1, IGFBP‐2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 90-day complications
Endpoint domain: Adverse events/effects
Primary endpoint: 5-month prolonged abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-week smoking cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants reporting restriction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of post-intubation tachycardia episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean heart rate after orotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cure rate of fungal skin diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with therapeutic effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ∆Lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: absolute AnLa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sense of belonging
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gonorrhea and chlamydia test uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Axial length (AL) elongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understandability of the scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inter- and intra-observer reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of phototherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correlation between predicted and measured ELP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of false positives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score of performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assistance required during cadaver drilling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain glycerol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain tissue damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIEF‐15 sexual desire domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: qADAM score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of SIRT1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of SIRT3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of PGC1‐α
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean changes in the Sharp/van der Heijde modified score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Opportunities for in-person contact with relatives in LTC
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Information about relatives' health and well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Supports for bereaved caregivers addressing complicated grief
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: IIEF-6 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of microbial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diagnostic yield of cellblocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-BP-S total score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term weight loss maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intravenous fluid requirement during CPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma-free hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum concentrations of epinephrine and noradrenaline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AGAD severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month neurologic outcome
Endpoint domain: Mortality/survival
Primary endpoint: hemi-mMASI improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in total modifiable cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child development status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diarrhoea prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cumulative survival rates of sealants
Endpoint domain: Mortality/survival
Primary endpoint: Average survival time of sealants
Endpoint domain: Mortality/survival
Primary endpoint: Diabetes self-management
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Cost-effectiveness for deep venous thrombosis (DVT)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost-effectiveness for clinically-relevant non-major bleeding (CRNMB)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Constant‐Murley Scale (CMS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficiency of bedside ward rounds
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient knowledge about medical care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient confusion about medical jargon
Endpoint domain: Adverse events/effects
Primary endpoint: 25 feet walking duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breast cancer knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: willingness to take prohibited substances
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: psychological need frustration
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: antidoping knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dissatisfaction with interpretation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ineffectiveness of interpretation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tender points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective feeling and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of change in mean deviation (MD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angina stability score of SAQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive decline in word list recognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive decline in constructional recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: incidence of depression and depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preoperative anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peak Exercise Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FADS2 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FADS1 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bronchoalveolar lavage concentration of tumor necrosis factor alpha (TNFα)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in HCLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean reduction in VAS score at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cavity local recurrence rates at 1 and 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Amount of vegetables served
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variety of vegetables served
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vestibular-ocular reflex improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD3+T, CD4+T, CD8+T cell count and immunoglobulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intestinal function recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral irritation
Endpoint domain: Adverse events/effects
Primary endpoint: Performance in ADLs (FIM scores)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to complete the 40 km cycling time trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-body fat oxidation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HAE attack rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in functional strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of appropriate treatment prescribed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who spent less than 1 day in hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: GC mortality
Endpoint domain: Mortality/survival
Primary endpoint: GC incidence
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in carer burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: mean number of days with peak COWS score less than or equal to 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in peak intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caregiver comfort level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of preparedness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: discharge readiness scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in fibrosis and hepatocyte ballooning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Estimated V̇O2max improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean concentration of rabies virus neutralizing antibodies (RVNAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NIH-CPSI scores regarding pain or discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIH-CPSI scores of symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of leukocytes number in the prostatic fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Response rates measured by BADDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes